Correlation Engine 2.0
Clear Search sequence regions


  • humans (1)
  • nifurtimox (8)
  • pharmacy (1)
  • Sizes of these terms reflect their relevance to your search.

    Nifurtimox is a nitroheterocyclic drug employed for treatment of trypanosomiases (Chagas disease and West African sleeping sickness); its use for certain cancers has also been assessed. Despite having been in the market for over 50 years, knowledge of nifurtimox is still fragmentary and incomplete. Relevant aspects of the chemistry and biology of nifurtimox are reviewed to summarize the current knowledge of this drug. These comprise its chemical synthesis and the preparation of some analogues, as well as its chemical degradation. Selected physical data and physicochemical properties are also listed, along with different approaches toward the analytical characterization of the drug, including electrochemical (polarography, cyclic voltammetry), spectroscopic (ultraviolet-visible, nuclear magnetic resonance, electron spin resonance), and single crystal X-ray diffractometry. The array of polarographic, ultraviolet-visible spectroscopic, and chromatographic methods available for the analytical determination of nifurtimox (in bulk drug, pharmaceutical formulations, and biological samples), are also presented and discussed, along with chiral chromatographic and electrophoretic alternatives for the separation of the enantiomers of the drug. Aspects of the drug likeliness of nifurtimox, its classification in the Biopharmaceutical Classification System, and available pharmaceutical formulations are detailed, whereas pharmacological, chemical, and biological aspects of its metabolism and disposition are discussed. Copyright © 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

    Citation

    Aldana B Moroni, Natalia L Calvo, Teodoro S Kaufman. Selected Aspects of the Analytical and Pharmaceutical Profiles of Nifurtimox. Journal of pharmaceutical sciences. 2023 Jun;112(6):1523-1538

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36822273

    View Full Text